A critical review of the role of M2PYK in the Warburg effect - PubMed
Review
A critical review of the role of M2PYK in the Warburg effect
Robert A Harris et al. Biochim Biophys Acta Rev Cancer. 2019 Apr.
Abstract
It is becoming generally accepted in recent literature that the Warburg effect in cancer depends on inhibition of M2PYK, the pyruvate kinase isozyme most commonly expressed in tumors. We remain skeptical. There continues to be a general lack of solid experimental evidence for the underlying idea that a bottle neck in aerobic glycolysis at the level of M2PYK results in an expanded pool of glycolytic intermediates (which are thought to serve as building blocks necessary for proliferation and growth of cancer cells). If a bottle neck at M2PYK exists, then the remarkable increase in lactate production by cancer cells is a paradox, particularly since a high percentage of the carbons of lactate originate from glucose. The finding that pyruvate kinase activity is invariantly increased rather than decreased in cancer undermines the logic of the M2PYK bottle neck, but is consistent with high lactate production. The "inactive" state of M2PYK in cancer is often described as a dimer (with reduced substrate affinity) that has dissociated from an active tetramer of M2PYK. Although M2PYK clearly dissociates easier than other isozymes of pyruvate kinase, it is not clear that dissociation of the tetramer occurs in vivo when ligands are present that promote tetramer formation. Furthermore, it is also not clear whether the dissociated dimer retains any activity at all. A number of non-canonical functions for M2PYK have been proposed, all of which can be challenged by the finding that not all cancer cell types are dependent on M2PYK expression. Additional in-depth studies of the Warburg effect and specifically of the possible regulatory role of M2PYK in the Warburg effect are needed.
Copyright © 2019 Elsevier B.V. All rights reserved.
Figures

Synthetic data for two isozymes with different KM values as a demonstration that reduced substrate affinity of an isozyme alone is not sufficient to predict activity in the cell. If substrate concentrations are sufficiently high in the cell (indicated by gray column) two isozymes with different affinity for substrate can give rise to the same level of activity. The Michaelis Menten equation was used to generate synthetic data in the left panel here and in Figures 2, and 4. Data in the left panel are hyperbolic (consistent with M1PYK data) on a linear x-axis, but appear sigmoidal in this figure due to the logarithmic scale of the x-axis. Data in the middle panel were derived from the Hill equation (with a nH value equal to 3). The resulting sigmoidal response is more representative of that found for M2PYK. The panel on the right compares a hyperbolic response with a higher substrate affinity (representing M1PYK) to a sigmoidal response with a lower substrate affinity (representing M2PYK). As exemplified in this figure, the ideas discussed in the text can be represented by the simpler comparison of hyperbolic data. Therefore, all other figures in this review include only data generated from the simpler Michaelis Menten equation. Nonetheless, the reader should keep in mind that M2PYK has a sigmoidal response.

Synthetic Data for two isozymes with altered KM and enzyme increased enzyme concentration and/or increased Vmax activity to demonstrate the possibility that an isozyme with lower substrate affinity can give rise to higher activity even at sub-saturating substrate concentrations, if it also has either higher specific activity or if it is expressed at higher concentrations.

A role for altered affinity of cancer M2PYK for PEP in creating a new steady-state in Warburg metabolism. The top panel represents the activity response curves of either normal PYK or cancer M2PYK. “Normal” PYK can be M1PYK, LPYK, RPYK, or M2PYK isolated from normal tissue. Concentrations of PEP in the cell are represented by red boxes and the respective PYK activity at that PEP concentration is represented by black dashes intersecting the red box (also marked with letters A and B at the beginning and the two steady-state PYK activities) and the response curve. The blue arrows trace changes related to the progression to cancer: 1) The PYK isozyme changes to cancer M2PYK, which has little activity at the PEP concentration present in normal tissue. 2) PEP concentrations build up due to reduced PYK activity. 3) Due to increased substrate availability caused by PEP build up, the cancer form of M2PYK has activity at high PEP. This condition maintains high levels of glycolytic intermediates and allows for high flux to lactic acid production. Green arrows connect the two steady-state PYK activities (A and B) with panels representing the respective metabolism. In these two lower panels, the thickness of arrows is intended to represent the relative concentrations of intermediates in the pathway indicated by the respective arrow. Left) When normal PYK is expressed, normal metabolism is at a steady-state and in the presence of O2, that steady-state flux of carbon from sugar into the mitochondria for oxidative phosphorylation. Right) When cancer M2PYK is expressed, a new steady-state flux is established that includes higher concentrations of glycolytic intermediates. This includes high rates of flux through the cancer PYK reaction and increased production of lactic acid. We anticipate higher flux through the mitochondria as well, thus generating higher levels of reactive oxygen species (ROS) and oxidative stress. However, the increased concentration of glucose 6-phosphate in the new steady-state condition drives increased flux through the pentose phosphate pathway due to substrate availability. This change produces increased NADPH. NADPH is needed to regenerate glutathione, which counteracts the increased oxidative stress, thus allowing cancer cells to live with higher intracellular ROS concentrations.

A theoretical response curve of normal PYK and cancer M2PYK, if “inhibited” cancer M2PYK involves reduced kcat. Here 5% activity compared to Normal PYK is used as an example, although the points in the text are more relevant if inhibition removes all catalytic activity. “Normal” PYK can be M1PYK, LPYK, RPYK, or M2PYK isolated from normal tissue. In the absence of changes in M2PYK expression, the only way to increase flux through the PYK reaction would be to activate the M2PYK protein, thus requiring a dynamic control of M2PYK to achieve both inhibition for build-up of glycolytic intermediates and to allow sufficient flux through the PYK reaction to generate high levels of lactic acid. The need for that dynamic regulation might predict oscillating flux of high glycolytic intermediate dispersed with periods of high lactic acid production.
Similar articles
-
M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation.
Morgan HP, O'Reilly FJ, Wear MA, O'Neill JR, Fothergill-Gilmore LA, Hupp T, Walkinshaw MD. Morgan HP, et al. Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5881-6. doi: 10.1073/pnas.1217157110. Epub 2013 Mar 25. Proc Natl Acad Sci U S A. 2013. PMID: 23530218 Free PMC article.
-
An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor.
Yuan M, McNae IW, Chen Y, Blackburn EA, Wear MA, Michels PAM, Fothergill-Gilmore LA, Hupp T, Walkinshaw MD. Yuan M, et al. Biochem J. 2018 May 31;475(10):1821-1837. doi: 10.1042/BCJ20180171. Biochem J. 2018. PMID: 29748232 Free PMC article.
-
Redox regulation of pyruvate kinase M2 by cysteine oxidation and S-nitrosation.
Mitchell AR, Yuan M, Morgan HP, McNae IW, Blackburn EA, Le Bihan T, Homem RA, Yu M, Loake GJ, Michels PA, Wear MA, Walkinshaw MD. Mitchell AR, et al. Biochem J. 2018 Oct 31;475(20):3275-3291. doi: 10.1042/BCJ20180556. Biochem J. 2018. PMID: 30254098 Free PMC article.
-
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S. Mazurek S. Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Int J Biochem Cell Biol. 2011. PMID: 20156581 Review.
-
Bayley JP, Devilee P. Bayley JP, et al. Curr Opin Oncol. 2012 Jan;24(1):62-7. doi: 10.1097/CCO.0b013e32834deb9e. Curr Opin Oncol. 2012. PMID: 22123234 Review.
Cited by
-
Niepmann M. Niepmann M. Cancers (Basel). 2024 Jun 21;16(13):2290. doi: 10.3390/cancers16132290. Cancers (Basel). 2024. PMID: 39001354 Free PMC article. Review.
-
Nikoo A, Roudkenar MH, Sato T, Kuwahara Y, Tomita K, Pourmohammadi-Bejarpasi Z, Najafi-Ghalehlou N, Roushandeh AM. Nikoo A, et al. Hum Cell. 2023 Jul;36(4):1441-1450. doi: 10.1007/s13577-023-00896-5. Epub 2023 Mar 24. Hum Cell. 2023. PMID: 36961656
-
Zalpoor H, Aziziyan F, Liaghat M, Bakhtiyari M, Akbari A, Nabi-Afjadi M, Forghaniesfidvajani R, Rezaei N. Zalpoor H, et al. Cell Commun Signal. 2022 Nov 23;20(1):186. doi: 10.1186/s12964-022-00951-y. Cell Commun Signal. 2022. PMID: 36419156 Free PMC article. Review.
-
Rothman DL, Shulman RG. Rothman DL, et al. Neoplasia. 2021 Sep;23(9):879-886. doi: 10.1016/j.neo.2021.06.004. Epub 2021 Jul 21. Neoplasia. 2021. PMID: 34303218 Free PMC article. Review.
-
Pyruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway.
Lewandowski SL, Cardone RL, Foster HR, Ho T, Potapenko E, Poudel C, VanDeusen HR, Sdao SM, Alves TC, Zhao X, Capozzi ME, de Souza AH, Jahan I, Thomas CJ, Nunemaker CS, Davis DB, Campbell JE, Kibbey RG, Merrins MJ. Lewandowski SL, et al. Cell Metab. 2020 Nov 3;32(5):736-750.e5. doi: 10.1016/j.cmet.2020.10.007. Cell Metab. 2020. PMID: 33147484 Free PMC article.
References
-
- O’Connell K, Doran P, Gannon J, Ohlendieck K, Lectin-based proteomic profiling of aged skeletal muscle: decreased pyruvate kinase isozyme M1 exhibits drastically increased levels of N-glycosylation, Eur J Cell Biol, 87 (2008) 793–805. - PubMed
-
- Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW, Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications, Mol Cell Proteomics, 1 (2002) 791–804. - PubMed
-
- Champattanachai V, Netsirisawan P, Chaiyawat P, Phueaouan T, Charoenwattanasatien R, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J, Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer, Proteomics, 13 (2013) 2088–2099. - PubMed
-
- Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V, Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells, Oncol Rep, 34 (2015) 1933–1942. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources